Deepti Behl
0000-0002-8247-5055
1 paper found
Refreshing results…
Pertuzumab Plus Trastuzumab in Patients With Lung Cancer With ERBB2 Mutation or Amplification: Results From the Targeted Agent and Profiling Utilization Registry Study
Missing publications? Search for publications with a matching author name.